Gossamer Bio reported a quarterly loss of $0.21 per share versus the Zacks consensus loss of $0.20, missing by $0.01 and widening from a $0.15 loss a year ago. The small miss and year-over-year deterioration are modestly negative and could pressure the stock near term; no guidance was included in the item.
Gossamer Bio reported a quarterly loss of $0.21 per share versus the Zacks consensus loss of $0.20, missing by $0.01 and widening from a $0.15 loss a year ago. The small miss and year-over-year deterioration are modestly negative and could pressure the stock near term; no guidance was included in the item.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
